Skip to main content
. 2021 Mar 29;77(13):1644–1655. doi: 10.1016/j.jacc.2021.02.023

Table 5.

Factors Compared Based on Mild Versus Severe Cases

Mild Case Severe Case p Value
Demographics
 Age, yrs 32 ± 16 40 ± 23 0.001
 Male 454/963 (47) 52/76 (68) <0.001
 Weight, kg 77.5 ± 20.8 83.0 ± 33.0 0.16
 Height, cm 168 ± 11 166 ± 12 0.063
 Body mass index 27.2 ± 6.5 29.2± 9.9 0.091
 Smoking/vaping history 76/967 (7.9) 5/77 (6.5) 0.66
 Black 62/739 (8.4) 6/45 (13.3) 0.25
 Hispanic 93/695 (14) 9/44 (21) 0.19
Medications
 ACE/ARB use 255/953 (27) 28/76 (37) 0.058
 Beta-blocker use 325/956 (34) 35/75 (46) 0.027
Medical/cardiac history
 Previous atrial arrhythmia 233/950 (25) 26/76 (34) 0.061
 Pacemaker or implantable defibrillator 119/956 (12) 13/77 (17) 0.26
 Hypertension 147/951 (16) 14/76 (18) 0.49
 Diabetes 50/961 (5.2) 15/77 (20) <0.001
 Known coronary artery disease 20/952 (2.1) 4/76 (5.3) 0.079
 Previous heart failure admission 72/951 (7.6) 26/74 (35) <0.001
 Ejection fraction <40% 29/617 (4.7) 6/56 (11) 0.052
 Systemic ventricular ejection fraction by echo 57 ± 10 53 ± 10 0.001
 Systemic right ventricle (biventricular) 51/967 (5.3) 10/77 (13) 0.005
 Moderate-severe valve dysfunction by echo 316/766 (41) 30/61 (49) 0.28
 Fontan palliation 108/964 (11.2) 10/77 (13) 0.64
 Pulmonary hypertension 58/955 (6.1) 15/77 (20) <0.001
 Sub-pulmonic ventricular systolic pressure by echo, mm Hg 38 ± 21 52 ± 28 0.006
 Previous resting oxygen saturation, % 96 ± 4 93 ± 6 <0.001
 Cyanosis (oxygen saturation <90%) 64/947 (6.8) 20/75 (27) <0.001
 Supplemental oxygen use 24/950 (2.5) 8/76 (10.5) <0.001
Laboratory findings
 Hemoglobin 14.21 ± 3.1 14.8± 2.8 0.105
 Creatinine, mg/dl 0.86 ± 0.34 1.12 ± 0.85 0.043
 eGFR <60 ml/min/1.73 m2 35/962 (3.6) 7/77 (9.1) 0.019
 Albumin, mg/dl 4.3 ± 0.6 4.0 ± 0.6 0.013

Values are mean ± SD or n/N (%).

Abbreviations as in Table 2.

Severe case includes need for intensive care, endotracheal intubation, renal replacement therapy, extracorporeal membrane oxygenation, or death.